Research Article

Dynamic Changes, Cut-Off Points, Sensitivity, and Specificity of Laboratory Data to Differentiate Macrophage Activation Syndrome from Active Disease

Table 4

The results of receiver operating characteristic (ROC) curve analysis for static variables.

ParameterROC-AUC valueCut-off valueSensitivitySpecificity95% confidence interval

WBC1 (×103/uL)0.500.960.33–0.66
WBC2 (×103/uL)0.770.00170%86%0.61–0.93
PMN1 (×103/uL)0.080.90.34–0.67
PMN2 (×103/uL)0.700.0260%85%0.53–0.86
Lymph1 (×103/uL)0.500.90.33–0.68
Lymph2 (×103/uL)0.83<0.00181%99.94%0.67–0.99
Hgb1 (g/dL)0.7330.0049.258%83%0.58–0.87
Hgb2 (g/dL) 0.83<0.0018.976%79%0.70–0.96
PLT1 (/microliter)0.760.00131650058%79%0.63–0.89
PLT2 (/microliter)0.96<0.00120400094%99.96%0.92–1.00
ESR1 (mm/h)0.410.30.22–0.60
ESR2 (mm/h)0.780.0015481%72%0.65–0.92
CRP1 (mg/L)0.710.0347.761%69%0.54–0.85
CRP2 (mg/L)0.630.1≥10358%69%0.47–0.79
ALT (u/L)0.85<0.0013882%84%0.73–0.97
AST (u/L)0.87<0.00138.582%78%0.76–0.98
ALP (U/L)0.420.4
ALB (gr/dl)0.860.0013.075%90%0.72–1.00
BilT (mg/dL)0.810.040.9866%84%0.59–1.00
BilD (mg/dL)0.690.20.42–0.96
Ferritin (ng/mL) 0.810.01527792%73%0.63–0.99
Fibrinogen (mg/dL)0.690.20.59–1.00
LDH (Iu/L)0.800.0282972%80%0.63–1.00
BUN (mg/dL)0.630.10.46–0.81
Cr (mg/dL)0.440.60.25–0.64
Na (meq/L)0.810.00513370%75%0.67–0.95
TG (mg/dL)0.790.10.49–1.00
Chol (mg/dL)0.610.60.064–1.00
PT0.740.0414.761.5%75%0.53–0.95
PTT0.790.013961990.62–0.97
INR0.800.011.1584%67%0.62–0.97

ROC-AUC: receiver operating characteristic-area under the curve, MAS: Macrophage Activation Syndrome, WBC: white blood cells, PMN: polymorphonuclear, Lymph: lymphocytes, Hgb: hemoglobin, PLT: platelet, ESR: erythrocyte sedimentation rate, CRP: C-reactive protein, ALT: alanine aminotransferase, AST: aspartate aminotransferase, ALB: albumin, Total Pr: total protein, Bil T: total bilirubin, Bil D: direct bilirubin, LDH: lactate dehydrogenase, BUN: blood urea nitrogen, Cr: creatinine, Na: natrium, TG: triglycerides, Chol: cholesterol, PT: prothrombin time, PTT: partial prothrombin time, and INR: international normalized ratio. The previous laboratory records: WBC1, PMN1, and so forth. The laboratory data at the onset of MAS (MAS group) or active rheumatologic disease (control group): WBC2, PMN2, and so forth. The laboratory data 1 month after discharge from the hospital: WBC3, PMN3, and so forth.